Medical Properties Trust demonstrates real-world asset value with $680 million in Q3 cash proceeds from hospital and Infracore sales. Recent hospital sales achieved 60–72% gains over original investments, supporting MPT's ability to monetize assets above book value. Proceeds are earmarked for debt reduction, improving leverage and partially offsetting FFO/AFFO headwinds from higher refinancing rates.
Medical Properties Trust stock continued its strong downward this week, reaching its lowest level since January 13 last year. MPT dropped to $3.40, down by over 32% this year and by 83% in the last five years.
Medical Properties Trust remains fundamentally challenged, with high debt, rising funding costs, and persistent cash burn undermining sustainability. Recent distressed debt exchange refinanced $2.4 billion, easing short-term liquidity but pushing a $6.3 billion debt wall to 2032 at a 9.25% rate. Interest expenses are set to consume 55-57% of 2027 revenue, with ongoing negative cash flow and unsustainable dividends funded by additional debt.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Curtis Ellergodt Rothschild Investment LLC | 48,992 | $229,701.96 | $149,915.52 | -$79,786.44 | -34.73% |
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 117,527 | $542,970 | $359,632.62 | -$183,337.38 | -33.77% |
| ABB Alexander Bjornager Bonde Danske Bank A/S | 400 | $2,000 | $1,230 | -$770 | -38.5% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 7,565 | $37,758.74 | $23,148.9 | -$14,609.84 | -38.69% |
| NA Nizar Araji National Bank Of Canada /FI/ | 1,176 | $7,480.41 | $3,657.36 | -$3,823.05 | -51.11% |